share_log

联环药业(600513.SH):地高辛注射液获得药品注册证书

Jiangsu Lianhuan Pharmaceutical (600513.SH): Digoxin injection obtained pharmaceutical registration certificate.

Gelonghui Finance ·  Dec 2 16:51

On December 2, GELONGHUI reported that Jiangsu Lianhuan Pharmaceutical (600513.SH) announced that it recently received the 'Pharmaceutical Registration Certificate' approved and issued by the National Medical Products Administration, with the pharmaceutical name: Digoxin Injection. Digoxin Injection can be used to treat adults with mild to moderate heart failure, increase myocardial contractility in pediatric patients with heart failure, and control ventricular rate in patients with atrial fibrillation, atrial flutter with rapid ventricular rates, and supraventricular tachycardia.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment